PlentiPlex™ KIT Mastocytosis qPCR Assay provides a fast and easy diagnosis of the Mastocytosis condition, more specifically the detection of the KIT D816V mutation
Assays | Cancer diagnosis and stratification
PlentiPlex™ KIT Mastocytosis qPCR Assay provides a fast and easy diagnosis of the Mastocytosis condition, more specifically the detection of the KIT D816V mutation
PlentiPlex™ Mastocytosis assay is intended for the detection of the KIT D816V mutation, which is among the WHO criteria for the diagnosis of mastocytosis. PlentiPlex™ Mastocytosis Assay utilises PentaBase’s in-house production of custom DNA molecules based on our DNA chemistry, known as Intercalating Nucleic Acid (INA). This technology provides an analysis that discovers and identifies if the patient has a disorder characterised by the growth and accumulation of neoplastic mast cells in various organs, most commonly in the skin.
Advantages of PlentiPlex™ Mastocytosis:
The Assay follows WHO criteria
Applicable for large biopsies
2 formats (Ready-to-use & Dispense ready)
Enables further personalised cancer treatment
If provided with sufficient input of DNA of sufficient quality, the assay can detect 0.01% of KIT D816V mutated gDNA in a background of wild-type gDNA. As a result, it offers two versions (RTU and DR), and two configurations (Simplex and Multiplex) all in one single solution: The PlentiPlex™ Mastocytosis
1
Solution
1
Hour result time
2
Versions
1
Instrument
PentaBase systems for analysis
The PlentiPlex™ Mastocytosis CE IVD assays are now designed and validated to be used on BaseTyper™48.4(PentaBase PCR instrument) and the following instruments:
Rotor-Gene (Qiagen)
MX3000P/3005P (Agilent)
LightCycler® 96 + 480 (Roche)
CFX96TM (Bio-Rad)
ABI 7500/7900HT (Applied Biosystems)
MIC (Bio Molecular Systems)
MyGo Pro (IT-IS Life Science)
Are you interested in our assays for the diagnosis of the Matocytosis condition? Find a local distributor, become our distributor, or order your assay at PentaBase directly.